Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.

Atul GoyaleAnjly JainColette SmithMargarita PapatheodoridiMarta Guerrero MisasDavide RoccarinaLaura Iogna PratDimitri P MikhailidisDevaki NairEmmanuel Tsochatzis

Published in: PloS one (2021)

Increasing fibrosis severity in NAFLD is associated with differential expression of IL-6 and MMP-9. NIFI could be valuable for the prediction of advanced NAFLD fibrosis and potentially help avoid unnecessary interventions such as liver biopsy in low-risk patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
liver fibrosis
physical activity
prognostic factors
peritoneal dialysis
ultrasound guided
fine needle aspiration